Assessing Nimacimab + Incretin Combination Weight Loss Dynamics
This research demonstrated that nimacimab-driven weight loss is not a result of caloric deficit alone and further characterized weight rebound and maintenance benefits.
Related Documents:
Assessing Weight Loss Dynamics of Nimacimab/Incretin Combo: Slides